Group 1 - The core point of the article is that Tenda Technology (SZ 001379) held its fourth board meeting on October 23, 2025, to discuss the expected related party transactions for the year 2026 [1] - For the first half of 2025, Tenda Technology's revenue composition was 94.07% from fasteners and 5.93% from other businesses [1] - As of the report date, Tenda Technology has a market capitalization of 4.6 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine [1] - There is a contrast noted between the thriving secondary market and the cooling fundraising environment in the primary market for biomedicine [1]
腾达科技：10月23日召开董事会会议